Oxford Biodynamics

OBD · AIM · Health Care · mcap £16m · 0.1p

Beta Briefing, track record and bull & bear case are not ready for Oxford Biodynamics yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 29 companies are already wired into a briefing: browse them.

Financials · LTM to 31 Mar 26

Source: results 30 Jun 26 ↗

Going-concern uncertainty

Revenue: £1.2m
Operating profit: −£9.9m
Net income: −£9.9m
Free cash flow: −£8.0m
Net cash: £2.5m
Market cap: £13.4m
EV / EBIT: –
FCF yield: −59.2%
Price / book: 4.1×

Latest half-year · H1 Mar 26 vs H1 Mar 25 results 30 Jun 26 ↗

Revenue: £687k
Operating profit: −£4.7m
Net income: −£4.5m
Cash from operations: −£4.5m

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: H1 Mar 26 (six months to 31 Mar 26), published 30 Jun 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	LTM Mar 26	FY Sep 25
Revenue	1.2	1.1
Gross profit	0.6	0.5
Operating profit	(9.9)	(11.1)
Depreciation (owned assets)	0.4	0.4
Depreciation (right-of-use)	0.7	0.7
Amortisation	0.1	0.1
Share-based payments	0.8	0.5
Fair value gains / losses	0.0	0.0
Finance costs	(0.3)	(0.4)
Profit before tax	(10.1)	(11.4)
Tax	0.2	0.3
Net income (owners)	(9.9)	(11.2)
EPS basic	(0.2p)	(0.8p)
EPS diluted	(0.2p)	(0.8p)

	H1 Mar 26	vs H1 Mar 25	H2 Sep 25	H1 Mar 25
Revenue	0.7	+17%	0.5	0.6
Gross profit	0.3	+12%	0.2	0.3
Operating profit	(4.7)	n/m	(5.2)	(5.9)
Depreciation (owned assets)	0.2	−5%	0.2	0.2
Depreciation (right-of-use)	0.3	−4%	0.3	0.3
Amortisation	0.1	n/m	0.1	0.1
Share-based payments	0.4	+159%	0.3	0.2
Fair value gains / losses	0.0	n/m	0.0	0.0
Finance costs	(0.1)	−60%	(0.2)	(0.2)
Profit before tax	(4.6)	n/m	(5.5)	(5.9)
Tax	0.1	−18%	0.1	0.1
Net income (owners)	(4.5)	n/m	(5.4)	(5.8)
EPS basic	(0.1p)	–	(0.1p)	(0.7p)
EPS diluted	(0.1p)	–	(0.1p)	(0.7p)

	LTM Mar 26	FY Sep 25
Cash from operations	(7.2)	(7.6)
Interest paid	(0.2)	(0.2)
Tax paid	0.1	0.1
Capex (PP&E)	(0.0)	(0.0)
Capex (intangibles)	(0.1)	(0.2)
Lease principal paid	(0.7)	(0.7)
Shares issued	7.0	7.4

	H1 Mar 26	vs H1 Mar 25	H2 Sep 25	H1 Mar 25
Cash from operations	(4.5)	n/m	(2.7)	(4.9)
Interest paid	(0.1)	−18%	(0.1)	(0.1)
Tax paid	(0.0)	n/m	0.1	(0.0)
Capex (PP&E)	(0.0)	n/m	(0.0)	0.0
Capex (intangibles)	(0.0)	−76%	(0.1)	(0.2)
Lease principal paid	(0.6)	0%	(0.0)	(0.6)
Shares issued	7.0	−6%	0.0	7.4

	Latest Mar 26	FY Sep 25
Other intangibles	1.1	1.1
Property, plant & equipment	1.2	1.4
Inventories	0.2	0.2
Trade receivables	0.7	0.4
Cash	2.5	1.4
Current assets	3.8	2.3
Total assets	9.1	8.1
Trade payables	1.0	1.3
Lease liabilities, current	0.9	1.3
Current liabilities	1.9	2.6
Lease liabilities, non-current	3.4	3.8
Total liabilities	5.8	7.0
Total equity	3.3	1.1

	H1 Mar 26	H2 Sep 25	H1 Mar 25
Other intangibles	1.1	1.1	1.4
Property, plant & equipment	1.2	1.4	1.6
Inventories	0.2	0.2	0.3
Trade receivables	0.7	0.4	1.4
Cash	2.5	1.4	4.3
Current assets	3.8	2.3	6.7
Total assets	9.1	8.1	13.3
Trade payables	1.0	1.3	1.7
Lease liabilities, current	0.9	1.3	0.9
Current liabilities	1.9	2.6	2.6
Lease liabilities, non-current	3.4	3.8	4.3
Total liabilities	5.8	7.0	7.4
Total equity	3.3	1.1	5.9

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.